Key facts
- MPM BIOIMPACT is a venture capital firm based in BOSTON, MA with 9 tracked portfolio companies.
- Notable positions include ReCode Therapeutics, Umoja Biopharma, Protego Biopharma, Crossbow Therapeutics, Antiva Biosciences.
- MPM BIOIMPACT has 2 funds on record, raising $156.5M across the 2 that report a size.
- MPM BIOIMPACT reports $2.0B in regulatory assets under management across 14 private funds, per its SEC Form ADV (2026-04).
Registered with the SEC
Form ADV · 2026-04 · CRD 148467- Regulatory AUM
- $2.0B
- Private fund assets
- $3.5B
- Private funds
- 14 · 8 venture, 3 hedge, 3 other
- Staff
- 50
- Registered office
- BOSTON, MA
- SEC status
- Approved
Reports custody of client assets.
Source: SEC Investment Adviser Public Disclosure, Form ADV (registered as MPM ASSET MANAGEMENT LLC).
Free account
See the whole book
- ·Watchlist + alerts for MPM BIOIMPACT's activity
Create free account
No card required
Portfolio, priced
9 companies · by our current valuations| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| ReCode Therapeutics | — | $700.0M | — | |
| Umoja Biopharma | — | $420.0M | — | |
| Protego Biopharma | — | $216.5M | — | |
| Crossbow Therapeutics | — | $125.0M | — | |
| Antiva Biosciences | — | $123.0M | — | |
| Cardiac Dimensions | — | $118.3M | — | |
| Arialys Therapeutics | — | $112.0M | — | |
| DEKA Biosciences | — | $36.0M | — | |
| Aktis Oncology | Drug Discovery | — | — |
Funds
2 recorded- MPM BioImpact Innovations Equities Master, LP2024$131.1M
- MPM BioImpact Innovations Equities Fund, LTD.2024$25.4M
$156.5M raised across the 2 funds that report a size
Frequently asked
- What companies does MPM BIOIMPACT invest in?
- MPM BIOIMPACT has 9 recorded portfolio companies, including ReCode Therapeutics, Umoja Biopharma, Protego Biopharma, Crossbow Therapeutics.
- What is MPM BIOIMPACT's AUM?
- MPM BIOIMPACT manages approximately $2.0B in assets.